...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model.
【24h】

Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model.

机译:使用基于药效团的比较分子场分析模型对UGT1A9介导的天然黄酮醇的3-O-葡萄糖醛酸化进行三维定量构效关系研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Glucuronidation is often recognized as one of the rate-determining factors that limit the bioavailability of flavonols. Hence, design and synthesis of more bioavailable flavonols would benefit from the establishment of predictive models of glucuronidation using kinetic parameters [e.g., K(m), V(max), intrinsic clearance (CL(int)) = V(max)/K(m)] derived for flavonols. This article aims to construct position (3-OH)-specific comparative molecular field analysis (CoMFA) models to describe UDP-glucuronosyltransferase (UGT) 1A9-mediated glucuronidation of flavonols, which can be used to design poor UGT1A9 substrates. The kinetics of recombinant UGT1A9-mediated 3-O-glucuronidation of 30 flavonols was characterized, and kinetic parameters (K(m), V(max), CL(int)) were obtained. The observed K(m), V(max), and CL(int) values of 3-O-glucuronidation ranged from 0.04 to 0.68 muM, 0.04 to 12.95 nmol/mg/min, and 0.06 to 109.60 ml/mg/min, respectively. To model UGT1A9-mediated glucuronidation, 30 flavonols were split into the training (23 compounds) and test (7 compounds) sets. These flavonols were then aligned by mapping the flavonols to specific common feature pharmacophores, which were used to construct CoMFA models of V(max) and CL(int), respectively. The derived CoMFA models possessed good internal and external consistency and showed statistical significance and substantive predictive abilities (V(max) model: q(2) = 0.738, r(2) = 0.976, r(pred)(2) = 0.735; CL(int) model: q(2) = 0.561, r(2) = 0.938, r(pred)(2) = 0.630). The contour maps derived from CoMFA modeling clearly indicate structural characteristics associated with rapid or slow 3-O-glucuronidation. In conclusion, the approach of coupling CoMFA analysis with a pharmacophore-based structural alignment is viable for constructing a predictive model for regiospecific glucuronidation rates of flavonols by UGT1A9.
机译:葡糖醛酸化通常被认为是限制黄酮醇生物利用度的速率决定因素之一。因此,更多的生物利用性黄酮醇的设计和合成将受益于使用动力学参数[例如,K(m),V(max),固有清除率(CL(int))= V(max)/ K)建立葡萄糖醛酸糖化预测模型(m)]衍生为黄酮醇。本文旨在构建特定于位置(3-OH)的比较分子场分析(CoMFA)模型,以描述UDP-葡糖醛酸糖基转移酶(UGT)1A9介导的黄酮醇葡糖醛酸化作用,可用于设计较差的UGT1A9底物。表征了重组UGT1A9介导的30种黄酮醇的3-O-葡萄糖醛酸化反应的动力学,并获得了动力学参数(K(m),V(max),CL(int))。 3-O-葡萄糖醛酸化的观察到的K(m),V(max)和CL(int)值范围为0.04至0.68μM,0.04至12.95 nmol / mg / min和0.06至109.60 ml / mg / min,分别。为了模拟UGT1A9介导的葡萄糖醛酸糖化,将30种黄酮醇分成训练组(23种化合物)和测试组(7种化合物)。然后通过将黄酮醇映射到特定的共有特征药效基团来比对这些黄酮醇,后者分别用于构建V(max)和CL(int)的CoMFA模型。衍生的CoMFA模型具有良好的内部和外部一致性,并显示出统计学意义和实质性的预测能力(V(max)模型:q(2)= 0.738,r(2)= 0.976,r(pred)(2)= 0.735; CL (int)模型:q(2)= 0.561,r(2)= 0.938,r(pred)(2)= 0.630)。从CoMFA建模得出的轮廓图清楚地表明了与快速或慢速3-O葡萄糖醛酸化有关的结构特征。总之,将CoMFA分析与基于药效团的结构比对相结合的方法对于构建UGT1A9对黄酮醇的区域特异性葡萄糖醛酸化率的预测模型是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号